Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

NCT00326820 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1404

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Hypercalcemia of Malignancy
Metastatic Cancer

Interventions

DRUG: ibandronate sodium
DRUG: zoledronic acid
DRUG: Zolendronic Acid

Sponsor

Wales Cancer Trials Unit

Collaborators

[object Object]